Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.
Phase Genomics has raised $1.5M in total funding. The most recent round was Grant. The last funding was announced in March 2024.
Phase Genomics's investors include Bill & Melinda Gates Foundation, Congruent Ventures, Four Cities Capital, National Institutes of Health, National Institute of Allergy and Infectious Diseases.
Phase Genomics is headquartered in Seattle, United States.
Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.
Phase Genomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phase Genomics — Funding & Investors." VCBacked, March 4, 2024, https://www.vcbacked.co/company/phase-genomics. Accessed October 27, 2026.
VCBacked. (2024). Phase Genomics — Funding & Investors. Retrieved October 27, 2026, from https://www.vcbacked.co/company/phase-genomics
{{cite web |title=Phase Genomics — Funding & Investors |url=https://www.vcbacked.co/company/phase-genomics |website=VCBacked |access-date=October 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated